(Q24241812)

30 June 2019

review article

1 reference

title

Vaccines for preventing anthrax (English)

1 reference

30 June 2019

author

Sarah Donegan

series ordinal

1

0 references

author name string

Richard Bellamy

series ordinal

2

1 reference

30 June 2019

Carrol L Gamble

series ordinal

3

1 reference

30 June 2019

language of work or name

English

0 references

publication date

15 April 2009

1 reference

30 June 2019

Cochrane Database of Systematic Reviews

published in

1 reference

30 June 2019

issue

2

1 reference

30 June 2019

page(s)

CD006403

1 reference

30 June 2019

Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006403.PUB2

Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006403.PUB2

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006403.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006403.PUB2

Anthrax as a biological weapon, 2002: updated recommendations for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006403.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006403.PUB2

In vitro correlate of immunity in a rabbit model of inhalational anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006403.PUB2

Search for correlates of protective immunity conferred by anthrax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006403.PUB2

Vaccines for preventing anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006403.PUB2

Epidemiologic effectiveness of anthrax vaccine STI

21 January 2018

1 reference

12 December 2020

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial

1 reference

12 December 2020

Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine

1 reference

12 December 2020

Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine

1 reference

12 December 2020

Field Evaluation of a Human Anthrax Vaccine

1 reference

12 December 2020

Assessment of immunity and allergy after vaccination with dry combined anthrax vaccine

1 reference

12 December 2020

Post anthrax vaccine delayed hypersensitivity. II--delayed hypersensitivity in humans vaccinated against anthrax

1 reference

12 December 2020

10.1002/14651858.CD006403.PUB2

Identifiers

DOI

1 reference

30 June 2019

PMC publication ID

6532564

1 reference

30 June 2019

PubMed publication ID

19370633

1 reference

30 June 2019